Steven Cohn

Emailsmcohnutmbedu

h-index

Research activity per year

Research Strategic Pillar

The Chief Research Officer, has determined that UTMB research should be prioritized into six health communities. This researcher has received the following badge(s):

Research Strategic Pillar Keywords

Specialized Health

Fingerprint

Dive into the research topics where Steven Cohn is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

3 Completed
4 Active

A PHASE III, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREAT-THROUGH STUDY TO ASSESS THE EFFICACY AND SAFETY OF INDUCTION AND MAINTENANCE THERAPY WITH RO7790121 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
Cohn, S. (PI)
Genentech, Inc ( Award # )
4/28/25 → 4/27/29
Project: Research project
A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy with RO7790121 in Patients with Moderately to Severely Active Ulcerative Colitis
Cohn, S. (PI)
Genentech, Inc ( Award # )
3/10/25 → 3/9/29
Project: Research project
A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 for Induction, Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis.
Cohn, S. (PI)
Reistone Biopharma Company Limited ( Award # )
1/19/22 → 1/18/27
Project: Research project
Corrona Inflammatory Bowel Disease (IBD) Registry
Cohn, S. (PI)
CorEvitas, LLC ( Award # )
5/21/19 → 3/15/26
Project: Research project
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active Controlled, Treat-Through study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease
Cohn, S. (PI)
Eli Lilly ( Award # )
8/20/20 → 3/31/23
Project: Research project

44 Article
6 Chapter
2 Review article
1 Letter

Exclusive Enteral Nutrition Alleviates Th17-Mediated Inflammation via Eliminating Mechanical Stress–Induced Th17-Polarizing Cytokines in Crohn’s-like Colitis
Geesala, R., Zhang, K., Lin, Y., Johnson, J. C., Cong, Y., Cohn, S. & Shi, X. Z., Mar 1 2024, In: Inflammatory bowel diseases. 30, 3, p. 429-440 12 p.
Research output: Contribution to journal › Article › peer-review
6 Scopus citations
Mechanical stress-induced connective tissue growth factor plays a critical role in intestinal fibrosis in Crohn’s-like colitis
Lin, Y. M., Zhang, K., Geesala, R., Lipson, K. E., Qiu, S., Powell, D. W., Cohn, S. & Shi, X. Z., Aug 2024, In: American Journal of Physiology - Gastrointestinal and Liver Physiology. 327, 2, p. G295-G305
Research output: Contribution to journal › Article › peer-review
5 Scopus citations
Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome
Khan, A., Menon, R., Corning, B., Cohn, S., Kumfa, C. & Raji, M., Jan 1 2024, In: Therapeutic Advances in Gastroenterology. 18
Research output: Contribution to journal › Review article › peer-review

Open Access
GPR120 Inhibits Colitis Through Regulation of CD4⁺ T Cell Interleukin 10 Production
Yang, W., Liu, H., Xu, L., Yu, T., Zhao, X., Yao, S., Zhao, Q., Barnes, S., Cohn, S. M., Dann, S. M., Zhang, H., Zuo, X., Li, Y. & Cong, Y., Jan 2022, In: Gastroenterology. 162, 1, p. 150-165 16 p.
Research output: Contribution to journal › Article › peer-review

Open Access
58 Scopus citations
AIDS-associated Esophageal Plasmablastic Lymphoma
Abdulla, H. M. & Cohn, S., Jan 2021, In: Clinical Gastroenterology and Hepatology. 19, 1, p. A18
Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Steven Cohn, MD, PhD, AGAF, FACG

Personal profile

Research Strategic Pillar

Research Strategic Pillar Keywords

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

A PHASE III, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED, TREAT-THROUGH STUDY TO ASSESS THE EFFICACY AND SAFETY OF INDUCTION AND MAINTENANCE THERAPY WITH RO7790121 IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE

A Phase III, Multicenter, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Induction Therapy with RO7790121 in Patients with Moderately to Severely Active Ulcerative Colitis

A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 for Induction, Maintenance Therapy in Subjects with Moderately to Severely Active Ulcerative Colitis.

Corrona Inflammatory Bowel Disease (IBD) Registry

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo and Active Controlled, Treat-Through study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease

Exclusive Enteral Nutrition Alleviates Th17-Mediated Inflammation via Eliminating Mechanical Stress–Induced Th17-Polarizing Cytokines in Crohn’s-like Colitis

Mechanical stress-induced connective tissue growth factor plays a critical role in intestinal fibrosis in Crohn’s-like colitis

Mirtazapine for gastrointestinal and neuropsychological symptoms in older adults with irritable bowel syndrome

GPR120 Inhibits Colitis Through Regulation of CD4⁺ T Cell Interleukin 10 Production

AIDS-associated Esophageal Plasmablastic Lymphoma

Steven Cohn, MD, PhD, AGAF, FACG

Personal profile

Research Strategic Pillar

Research Strategic Pillar Keywords

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output